Dengue is endemic in more than 100 countries, and outbreaks can overwhelm health services [1]. There is no specific antiviral treatment: most symptomatic patients need careful observation and prompt but judicious intravenous fluid [2]. Two pieces of information drive almost every decision. The first is the WHO class, which places the patient as dengue without warning signs, dengue with warning signs, or severe dengue [3, 4]. The second is the phase of illness.
| Phase | Usual timing | What happens | Main risk |
|---|---|---|---|
| Febrile | First days of fever | High fever and viraemia; the NS1 antigen test is most useful now | Dehydration; warning signs missed |
| Critical | Around defervescence, usually days 3 to 7, lasting 24 to 48 hours | Plasma leakage, rising haematocrit, falling platelets | Shock, bleeding, organ impairment |
| Recovery | The following 2 to 3 days | Leaked fluid is reabsorbed; appetite and diuresis return | Fluid overload and pulmonary oedema |
Counting the day of illness from the first day of fever, and noting when the fever settles, is the most useful single habit. Defervescence marks the start of the period of greatest risk, not recovery.